Agenus Inc. (AGEN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Agenus Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$7.13
+7.22% today
Market cap
$300M
Overall quality
52/100
Kronos AI 30-day
−2.6%
4 of 8 simulated paths end higher
Agenus Inc. (AGEN) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $300M. It trades at $7.13, up 7.22% today, at 3.5 times earnings. Its overall quality score is 52 out of 100, ranked against the whole US market. 4 analysts' average target of $24.50 implies +243.6% from today's price. Kronos AI's 30-day forecast is −2.6% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $24.50 |
| Low – high | $14.00 – $40.00 |
| Analysts | 4 |
| Upside to average | +243.6% |
Kronos AI 30-day forecast
| Expected close | $6.48 (−2.6%) |
| Likely range | −13.9% … +11.1% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
| Profitability | 52 |
| Solvency | 34 |
| Growth | 71 |
| Overall | 52 |
| P/E | 3.5 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.